Showing results (5101-5110 of 9,342) with videos related to

Sort By:
Pageof 935
Cancer Medicine|August 8, 2023
Guanylate-binding proteins signature predicts favorable prognosis, immune-hot microenvironment, and immunotherapy response in hepatocellular carcinomaYumei Ning, Shilin Fang, Jun Fang, et al.
Cancer Medicine|August 10, 2023
Tools to assess employment readiness for colorectal cancer survivors: A scoping reviewMingshuang Ding, Elise Gane, Harry Wiffen, et al.
Cancer Medicine|August 7, 2023
Benefits and harms of breast cancer screening: Cohort study of breast cancer mortality and overdiagnosisSabrina Wang, Farhana Sultana, Anne Kavanagh, et al.
Cancer Medicine|August 9, 2023
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemiaMay Garrett, Beverly Knight, Jorge E Cortes, et al.
Cancer Medicine|August 8, 2023
β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanomaCornelia Schuster, Lars A Akslen, Oddbjørn Straume
Cancer Medicine|August 10, 2023
Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)Sabine Felser, Julia Rogahn, Lina Hollenbach, et al.
Cancer Medicine|August 4, 2023
Quantifying mortality burden in patients with cancer due to COVID-19 in the US: A national cross-sectional analysisBhaghyasree Jambunathan, Jacob Lang, Malik Mays, et al.
Cancer Medicine|August 4, 2023
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapyLaurent Zelek, Rudolph Navari, Matti Aapro, et al.
Cancer Medicine|August 1, 2023
Factors influencing treatment decision-making for cancer patients in low- and middle-income countries: A scoping reviewMarta Salek, Allison Silverstein, Alyssa Tilly, et al.
Cancer Medicine|July 31, 2023
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trialsJunki Mizusawa, Hioryuki Sato, Larry V Rubinstein, et al.
Pageof 935